ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2612

Localisation of Bone Marrow Edema in Sacroiliac Joints in Spondyloarthritis Patients: Does the Site of Lesions Change Over a 3-Month Period?

Manouk de Hooge1, Rosaline van den Berg1, Monique Reijnierse2, Victoria Navarro-Compán1, Floris van Gaalen1, Tom Huizinga1 and Désirée van der Heijde1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Bone marrow, inflammation and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Psoriatic Arthritis and Spondyloarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: A positive MRI at baseline is a strong predictor for a positive follow-up MRI1. But many questions about the volatility of the lesions over short follow-up periods remain unsolved. Is it possible for lesions to disappear, occur or move localisation? Or is their location rather consistent over time?

Objectives: To describe if and how the location of active inflammatory lesions change and if lesions can occur or disappear after 3 months without changing treatment.

Methods: 90 patients with chronic back pain (≥3 months, ≤2 years, onset ≤45 years) who were included in the SPondyloArthritis Caught Early (SPACE)-cohort underwent a MRI of the SI joints (MRI-SIJ) at baseline and after 3 months follow-up.

Results: Out of all the patients 66/90 (73.3%) did not show any lesions at any of the time points. In 12 patients no difference was found between baseline and follow-up MRI with respect to the SI joint (only left side affected in 7 patients, only right side in 2 and in 3 patients both SIJ were affected). In 5 patients without lesions at baseline new inflammation occurred (4 times only in the right SIJ and once in both SIJs). In 4 patients with inflammation at baseline the inflammation was no longer present at follow-up. In 3 out of 6 patients with inflammation in both SIJ at baseline, the inflammation was only present in the left SIJ after 3 months. The other 3 patients presented inflammation in both SIJ at baseline as well as follow-up. 24/90 (26.7%) patients had a positive MRI at baseline or follow-up, or both. The quadrant in which the lesion was present did not change over time in 6 patients. Lesions disappeared from quadrants in 9 patients (lesion disappeared in only 1 quadrant in 7 patients and in 3 quadrants in 2 patients) and occurred in 7 patients (MRI changed from negative to positive in 5 and remained positive in 2 patients). The lesions moved between quadrants in 2 patients. In these 2 patients lesions disappeared from one quadrant and occurred in another. In 20/24 patients the medication between baseline MRI and follow-up did not change (18 patients used NSAIDs and 2 of them did not use any medication) and 4 patients changed medication (2 patients switched NSAID type and the other 2 started NSAID treatment in that period). Out of the patients that changed from a negative to positive MRI (n=5) or visa versa (n=4), only 1 patient also changed medication, by switching to another NSAID.

Conclusion: BME lesions on MRI occur or disappear at SIJ level in 9% of the patients with chronic back pain after 3 months. From all patients with a positive MRI at baseline, lesions did not change location in 50% of them at SIJ level while, at quadrant level, less than 30% of the patients showed stability in the location of lesions. So, there is quite some volatility of lesions over a short follow-up period of 3 months only.

 

No. of patients

3-month follow-up

Baseline

 

No lesions

Only left

Only right

Both sides

 

No lesions

66

0

4

1

71

Only left

3

7

0

0

10

Only right

1

0

2

0

3

Both sides

0

3

0

3

6

 

70

10

6

4

90

 


Disclosure:

M. de Hooge,
None;

R. van den Berg,
None;

M. Reijnierse,
None;

V. Navarro-Compán,
None;

F. van Gaalen,
None;

T. Huizinga,
None;

D. van der Heijde,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/localisation-of-bone-marrow-edema-in-sacroiliac-joints-in-spondyloarthritis-patients-does-the-site-of-lesions-change-over-a-3-month-period/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology